LD-2 disclosure · 4th Quarter - Report
KAISER FOUNDATION HEALTH PLAN INC
via KAISER FOUNDATION HEALTH PLAN INC.
Client
- Location
- California · United States of America
Registrant
- Firm
- KAISER FOUNDATION HEALTH PLAN INC.
- Location
- Oakland, California, United States of America
Lobbying activities
6 issuesDefense
H.R.8070 - Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025 S. 4638 - the National Defense Authorization Act for Fiscal Year 2025 (NDAA) Legislation and regulation regarding the TRICARE program.
Lobbyistsmr LAIRD D BURNETT · MARY PRUDENCE FITZPATRICK · DAVID C BENNETT
TargetedSENATE · HOUSE OF REPRESENTATIVES
Pharmacy
Legislation and regulation regarding pharmaceutical pricing, coverage and care; retail and inpatient pharmacy operations and the role of pharmacy benefit managers. S.2140 - Patent Eligibility Restoration Act of 2023 H.R. 2679, the PBM Accountability Act H.R.3285 - To establish patient protections with respect to highly rebated drugs S. 1067, the Ensuring Timely Access to Generics Act of 2023 S. 1114, the Expanding Access to Low-Cost Generics Act of 2023 S.1269 - INSULIN Act of 2023 S. 1909 Pharmacy DIR Reform to Reduce Senior Drug Costs Act S. 1967 The Patients Before Middlemen Act (the PBM Act) S. 1339 The Pharmacy Benefit Managers Reform Act S. 127, the Pharmacy Benefit Manager Transparency Act of 2023 H.R. 485, the Protecting Health Care for All Patients Act of 2023 S. 2780 & H.R. 5429 - Medication Affordability and Patent Integrity Act S. 2305 - Biosimilar Red Tape Elimination Act S.150 & H.R. 9070 - Affordable Prescriptions for Patients Act of 2023 S. 5503 and H.R. 10362 - The Patients Before Monopolies Act
Lobbyistsmr LAIRD D BURNETT · MARY PRUDENCE FITZPATRICK · DAVID C BENNETT
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS)
